Table 3.
Countries | CRM for population< 40 years per million population< 40 years | BCG Coverage % under 40 years | CRM for population 20–29 years per million population 20–29 years | BCG Coverage % for age groups of 20–29 | CRM for population 30–39 per million population 30–39 years | BCG Coverage % for age groups of 30–39 |
---|---|---|---|---|---|---|
Sweden | 3.4 | 0 | 4.6 | 0 | 8.4 | 0 |
Italy | 2.3 | 0 | 1.2 | 0 | 6.3 | 0 |
Netherlands | 1.8 | 0 | 2.4 | 0 | 4.7 | 0 |
Switzerland | 1.2 | Not reported | 0.0 | 0 | 4.3 | Not reported |
Czech Republic | 1.1 | 74 | 0.8 | 78 | 2.6 | 98 |
Poland | 0.7 | 94 | 0.0 | 96 | 2.3 | 95 |
South Korea | 0.0 | 77 | 0.0 | 84 | 0.1 | 53 |
Countries with lower rates of BCG coverage generally have higher rates of CRM suggesting that, even in a less vulnerable population, BCG vaccination is associated with improved CRM.